Malcolm G P Page

Title: The Innovations of Malcolm G P Page

Introduction

Malcolm G P Page is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. With a total of 3 patents, his work focuses on enhancing the efficacy of treatments for bacterial infections.

Latest Patents

Among his latest patents, one includes "Useful combinations of monobactam antibiotics with beta-lactamase inhibitors." This patent details new monobactam antibiotic compounds that contain a 3-amino-azetidin-2-one ring, which are active against gram-negative bacteria. The compounds include the specific compound 2-(2-amino-thiazol-4-yl)-2-[(Z)-(1H,4H-1,5-dihydroxy-4-oxo-pyridin-2-yl)methoxyimino]-N-[3(S)-1-oxysulfonyl-2,2-dimethyl-4-oxo-azetidin-3-yl]acetamide. Another patent is titled "Combination medicaments for treating bacterial infections," which describes the use of a monobactam antibiotic for the manufacture of a medicament in combination with a carbapenem antibiotic.

Career Highlights

Malcolm G P Page is currently associated with Basilea Pharmaceutica AG, a company known for its innovative approaches in the pharmaceutical industry. His work has been instrumental in advancing antibiotic therapies, which are crucial in combating resistant bacterial strains.

Collaborations

He has collaborated with notable colleagues such as Eric Desarbre and Bérangére Gaucher, contributing to a dynamic research environment that fosters innovation in antibiotic development.

Conclusion

Malcolm G P Page's contributions to the field of pharmaceuticals, particularly in antibiotic development, highlight his role as a significant inventor. His patents reflect a commitment to improving treatment options for bacterial infections, showcasing the importance of innovation in healthcare.